Fujian Cosunter Pharmaceutical Co Ltd (300436) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.055x

Based on the latest financial reports, Fujian Cosunter Pharmaceutical Co Ltd (300436) has a cash flow conversion efficiency ratio of -0.055x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-25.74 Million ≈ $-3.77 Million USD) by net assets (CN¥468.48 Million ≈ $68.55 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Fujian Cosunter Pharmaceutical Co Ltd net asset quality index to measure how much of total assets are equity-financed.

Fujian Cosunter Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Fujian Cosunter Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Fujian Cosunter Pharmaceutical Co Ltd (300436) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Fujian Cosunter Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Fujian Cosunter Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
NFI Group Inc TO:NFI	0.202x
Ningbo Jifeng Auto Parts Co SHG:603997	0.112x
Autohome Inc ADR F:8AHB	N/A
IHS HOLDING LTD. DL-3 F:4JB	N/A
China Southern Airlines Company Limited F:ZNHH	0.192x
Navitas Semiconductor Corp NASDAQ:NVTS	-0.027x
Íslandsbanki hf. IC:ISB	0.079x
Feng Tay Enterprises Co Ltd TW:9910	0.069x

Annual Cash Flow Conversion Efficiency for Fujian Cosunter Pharmaceutical Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Fujian Cosunter Pharmaceutical Co Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see Fujian Cosunter Pharmaceutical Co Ltd (300436) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥346.30 Million ≈ $50.67 Million	CN¥-35.05 Million ≈ $-5.13 Million	-0.101x	-293.94%
2024-12-31	CN¥396.78 Million ≈ $58.06 Million	CN¥20.71 Million ≈ $3.03 Million	0.052x	+117.02%
2023-12-31	CN¥569.24 Million ≈ $83.30 Million	CN¥-174.60 Million ≈ $-25.55 Million	-0.307x	-144.91%
2022-12-31	CN¥955.62 Million ≈ $139.84 Million	CN¥-119.68 Million ≈ $-17.51 Million	-0.125x	-640.11%
2021-12-31	CN¥1.05 Billion ≈ $153.63 Million	CN¥-17.76 Million ≈ $-2.60 Million	-0.017x	-163.14%
2020-12-31	CN¥581.99 Million ≈ $85.16 Million	CN¥15.60 Million ≈ $2.28 Million	0.027x	-54.76%
2019-12-31	CN¥573.74 Million ≈ $83.96 Million	CN¥33.99 Million ≈ $4.97 Million	0.059x	+204.40%
2018-12-31	CN¥562.35 Million ≈ $82.29 Million	CN¥10.94 Million ≈ $1.60 Million	0.019x	-84.97%
2017-12-31	CN¥552.05 Million ≈ $80.78 Million	CN¥71.47 Million ≈ $10.46 Million	0.129x	-3.16%
2016-12-31	CN¥552.36 Million ≈ $80.83 Million	CN¥73.84 Million ≈ $10.81 Million	0.134x	-37.82%
2015-12-31	CN¥519.20 Million ≈ $75.97 Million	CN¥111.63 Million ≈ $16.33 Million	0.215x	-68.49%
2014-12-31	CN¥156.87 Million ≈ $22.96 Million	CN¥107.04 Million ≈ $15.66 Million	0.682x	+47.49%
2013-12-31	CN¥143.10 Million ≈ $20.94 Million	CN¥66.20 Million ≈ $9.69 Million	0.463x	+19.69%
2012-12-31	CN¥108.59 Million ≈ $15.89 Million	CN¥41.97 Million ≈ $6.14 Million	0.387x	-52.42%
2011-12-31	CN¥65.43 Million ≈ $9.58 Million	CN¥53.15 Million ≈ $7.78 Million	0.812x	--

About Fujian Cosunter Pharmaceutical Co Ltd

SHE:300436 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.13 Billion

CN¥14.55 Billion CNY

Market Cap Rank

#5910 Global

#1095 in China

Share Price

CN¥91.36

Change (1 day)

+0.96%

52-Week Range

CN¥73.20 - CN¥172.22

All Time High

CN¥172.22